Delivery of Chicken Egg Ovalbumin to Dendritic Cells by Listeriolysin O-Secreting Vegetative Bacillus subtilis = Delivery of Chicken Egg Ovalbumin to Dendritic Cells by Listeriolysin O-Secreting Vegetative Bacillus subtilis

다국어 초록 (Multilingual Abstract)

Listeriolysin O (LLO), one of the most immunogenic proteins of Listeria monocytogenes and its main virulence factor, mediates bacterial escape from the phagosome of the infected cell. Thus, its expression in a nonpathogenic bacterial host may enable effective delivery of heterologous antigens to the host cell cytosol and lead to their processing predominantly through the cytosolic MHC class I presentation pathway. The aim of this project was to characterize the delivery of a model antigen, chicken egg ovalbumin (OVA), to the cytosol of dendritic cells by recombinant Bacillus subtilis vegetative cells expressing LLO. Our work indicated that LLO produced by non-sporulating vegetative bacteria was able to support OVA epitope presentation by MHC I molecules on the surface of antigen presenting cells and consequently influence OVA-specific cytotoxic T cell activation. Additionally, it was proven that the genetic context of the epitope sequence is of great importance, as only the native full-sequence OVA fused to the N-terminal fragment of LLO was sufficient for effective epitope delivery and activation of CD8⁺ lymphocytes. These results demonstrate the necessity for further verification of the fusion antigen potency of enhancing the MHC I presentation, and they prove that LLO-producing B. subtilis may represent a novel and attractive candidate for a vaccine vector.

참고문헌 (Reference)

1 Sojka L, "YbxF, a protein associated with exponential-phase ribosomes in Bacillus subtilis" 189 : 4809-4814, 2007

2 Titball RW, "Vaccines against intracellular bacterial pathogens" 13 : 596-600, 2008

3 Gupta S, "Vaccination with a fusion protein that introduces HIV-1 Gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-Gag" 88 : 1492-1501, 2014

4 Carreno LJ, "The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge" 121 : 227-237, 2007

5 Antelmann H, "The extracellular proteome of Bacillus subtilis under secretion stress conditions" 49 : 143-156, 2003

6 Daniels MA, "TCR signaling in T cell memory" 6 : 617-, 2015

7 Ning D, "Surface-displayed VP28 on Bacillus subtilis spores induce protection against white spot syndrome virus in crayfish by oral administration" 111 : 1327-1336, 2011

8 Albaghdadi H, "Selectively reduced intracellular proliferation of Salmonella enterica serovar Typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response" 183 : 3778-3787, 2009

9 Westers L, "Secretion of functional human interleukin-3 from Bacillus subtilis" 123 : 211-224, 2006

10 Kakeshita H, "Secretion of biologically-active human interferonbeta by Bacillus subtilis" 33 : 1847-1852, 2011

11 VanCott JL, "Regulation of host immune responses by modification of Salmonella virulence genes" 4 : 1247-1252, 1998

12 Sewell DA, "Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumorassociated antigen human papillomavirus-16 E7" 64 : 8821-8825, 2004

13 Radford KJ, "Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cells" 105 : 811-819, 2003

14 Yang E, "Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice" 69-70 : 53-59, 2014

15 Pohl S, "Proteomic analysis of Bacillus subtilis strains engineered for improved production of heterologous proteins" 13 : 3298-3308, 2013

16 McBride BW, "Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers" 16 : 810-817, 1998

17 Airaksinen U, "Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model" 10 : 367-375, 2003

18 Schnupf P, "Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence" 8 : 353-364, 2006

19 Savina A, "Phagocytosis and antigen presentation in dendritic cells" 219 : 143-156, 2007

20 Trovato M, "Novel antigen delivery systems" 4 : 156-168, 2015

21 Wei CH, "N-terminal trimer extension of nominal CD8 T cell epitopes is sufficient to promote crosspresentation to cognate CD8 T cells in vivo" 179 : 8280-8286, 2007

22 Youngman P, "Methods for genetic manipulation, cloning, and functional analysis of sporulation genes in Bacillus subtilis;Regulation of Prokaryotic Development" 65-87, 1989

23 Lin IY, "Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery" 3 : 940-972, 2015

24 Carrero JA, "Listeriolysin O is strongly immunogenic independently of its cytotoxic activity" 7 : e32310-, 2012

25 Vazquez-Boland JA, "Listeria pathogenesis and molecular virulence determinants" 14 : 584-640, 2001

26 Jawa V, "Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience;Fusion Protein Technologies for Biopharmaceuticals" John Wiley & Sons, Inc 75-90, 2013

27 Pamer EG, "Immune responses to Listeria monocytogenes" 4 : 812-823, 2004

28 Rudolph MG, "How TCRs bind MHCs, peptides, and coreceptors" 24 : 419-466, 2006

29 Li Pira G, "High throughput T epitope mapping and vaccine development" 2010 : 325720-, 2010

30 Olmos-Soto J, "Genetic system constructed to overproduce and secrete proinsulin in Bacillus subtilis" 62 : 369-373, 2003

31 Singh R, "Fusion to listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse" 175 : 3663-3673, 2005

32 Cheng WF, "Fusion protein vaccines targeting two tumor antigens generate synergistic anti-tumor effects" 8 : e71216-, 2013

33 Bahey-El-Din M, "Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors" 59 : 904-912, 2010

34 Hinc K, "Expression and display of UreA of Helicobacter acinonychis on the surface of Bacillus subtilis spores" 9 : 2-, 2010

35 Negri A, "Expression and display of Clostridium difficile protein FliD on the surface of Bacillus subtilis spores" 62 : 1379-1385, 2013

36 Sette A, "Epitope-based vaccines: an update on epitope identification, vaccine design and delivery" 15 : 461-470, 2003

37 Kohda C, "Dissociated linkage of cytokine-inducing activity and cytotoxicity to different domains of listeriolysin O from Listeria monocytogenes" 70 : 1334-1341, 2002

38 Mauriello EM, "Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner" 22 : 1177-1187, 2004

39 Lee S, "Development of a Bacillus subtilisbased rotavirus vaccine" 17 : 1647-1655, 2010

40 Cohn L, "Dendritic cell-targeted vaccines" 5 : 255-, 2014

41 Stachowiak R, "Cytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cells" 14 : 77-, 2014

42 Stachowiak R, "Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets" 2012 : 954375-, 2012

43 Stachowiak, R., "Cytotoxicity of Listeriolysin O Produced by Membrane-Encapsulated Bacillus subtilis on Leukemia Cells" 한국미생물·생명공학회 21 (21): 1193-1198, 2011

44 Huang JM, "Cytoplasmic delivery of antigens, by Bacillus subtilis enhances Th1 responses" 26 : 6043-6052, 2008

45 Becavin C, "Comparison of widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic variations underlying differences in pathogenicity" 5 : e00969-e00914, 2014

46 Luiz WB, "Boosting systemic and secreted antibody responses in mice orally immunized with recombinant Bacillus subtilis strains following parenteral priming with a DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) CFA/I fimbriae B subunit" 26 : 3998-4005, 2008

47 Duc le H, "Bacterial spores as vaccine vehicles" 71 : 2810-2818, 2003

48 Mader U, "Bacillus subtilis functional genomics: genomewide analysis of the DegS-DegU regulon by transcriptomics and proteomics" 268 : 455-467, 2002

49 Gomes PA, "Antibody responses elicited in mice immunized with Bacillus subtilis vaccine strains expressing Stx2B subunit of enterohaemorragic Escherichia coli O157:H7" 40 : 333-338, 2009

50 Radford KJ, "A recombinant E. coli v accine t o promote MHC class I-dependent antigen presentation: application to cancer immunotherapy" 9 : 1455-1463, 2002

51 Schulke S, "A fusion protein consisting of the vaccine adjuvant monophosphoryl lipid A and the allergen ovalbumin boosts allergen-specific Th1, Th2, and Th17 responses in vitro" 2016 : 4156456-, 2016

52 Decatur AL, "A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity" 290 : 992-995, 2000